The company has analysed the data and reported their conclusions. This does need to be looked at objectively but surely they understand sufficiently to give reasoned analysis - which they indicate the results are significant. I read that there are bright spots but proof of pudding is BIT taking it further. Encouraged by following statements in conclusion comments in the poster:
"The BIT225 cohort had a significantly greater reduction of the macrophage activation marker sCD163, a good indicator of all cause morbidity and mortality in HIV-1 patients. Additional reduction of this marker in patients taking BIT225 demonstrates significant immunological benefit.
In particular:
The commencement of a decline of activated CD4+ cell levels at week 6 suggests that virus from these reservoir cells is being eradicated, and cleared by week 12 when levels return to those seen in the ART + placebo cohort."
Still, DYOR but guilty of picking up some low priced OBs this morning
- Forums
- ASX - By Stock
- BIT
- Catalysts for $1B MC?
Catalysts for $1B MC?, page-174
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $29.77M |
Open | High | Low | Value | Volume |
3.4¢ | 3.5¢ | 3.3¢ | $8.412K | 247.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 139827 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 76443 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 139827 | 0.033 |
4 | 842406 | 0.032 |
2 | 340500 | 0.031 |
9 | 670666 | 0.030 |
1 | 100000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 76443 | 2 |
0.036 | 65500 | 1 |
0.037 | 537816 | 2 |
0.039 | 490546 | 3 |
0.040 | 263240 | 3 |
Last trade - 15.43pm 17/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |